Immediate hypersensitivity reaction to gadolinium-based MR contrast media

Radiology

Volumn 264, Issue 2, 2012, Pages 414-422

  Jung, Jae Woo ^a,b,c   Kang, Hye Ryun ^a,b   Kim, Min Hye ^a   Lee, Whal ^a   Min, Kyung Up ^a   Han, Moon Hee ^a   Cho, Sang Heon ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Chung Ang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DOPAMINE; GADOBENATE DIMEGLUMINE; GADOBUTROL; GADODIAMIDE; GADOLINIUM PENTETATE; GADOTERATE MEGLUMINE; GADOXETIC ACID; NORADRENALIN;

ADULT; AGE; ALLERGIC RHINITIS; ALLERGY; ANALYSIS OF VARIANCE; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; BRONCHOSPASM; CHRONIC URTICARIA; COMORBIDITY; CONFIDENCE INTERVAL; DEMOGRAPHY; DRUG FATALITY; DRUG HYPERSENSITIVITY; ELECTRONIC MEDICAL RECORD; FEMALE; FISHER EXACT TEST; FOOD ALLERGY; HUMAN; HYPOTENSION; IMMEDIATE TYPE HYPERSENSITIVITY; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RECURRENCE RISK; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STUDENT T TEST; SYMPTOM; URTICARIA;

ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INCIDENCE; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECURRENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84864353567     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112025     Document Type: Article

References (25)

1. Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC. Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults. AJR Am J Roentgenol 2007;189(6):1533-1538. (Pubitemid 350174833)
2. Grobner T. Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21(4):1104-1108.
3. Marckmann P, Skov L. Nephrogenic systemic fibrosis: clinical picture and treatment. Radiol Clin North Am 2009;47(5):833-840.
4. Runge VM. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging 2000;12(2):205-213. (Pubitemid 30612863)
5. Weiss KL. Severe anaphylactoid reaction after i.v. Gd-DTPA. Magn Reson Imaging 1990;8(6):817-818.
6. Tardy B, Guy C, Barral G, Page Y, Ollagnier M, Bertrand JC. Anaphylactic shock induced by intravenous gadopentetate dimeglumine. Lancet 1992;339(8791):494.
7. Bleicher AG, Kanal E. Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine. AJR Am J Roentgenol 2008;191(6):W307-W311.
8. Hunt CH, Hartman RP, Hesley GK. Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses. AJR Am J Roentgenol 2009;193(4):1124-1127.
9. Li A, Wong CS, Wong MK, Lee CM, Au Yeung MC. Acute adverse reactions to magnetic resonance contrast media: gadolinium chelates. Br J Radiol 2006;79(941):368-371. (Pubitemid 43676338)
10. Kirchin MA, Runge VM. Contrast agents for magnetic resonance imaging: safety update. Top Magn Reson Imaging 2003;14(5):426-435. (Pubitemid 37521732)
11. Prince MR, Zhang H, Zou Z, Staron RB, Brill PW. Incidence of immediate gadolinium contrast media reactions. AJR Am J Roentgenol 2011;196(2):W138-W143.
12. Murphy KP, Szopinski KT, Cohan RH, Mermillod B, Ellis JH. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors. Acad Radiol 1999;6(11):656-664. (Pubitemid 32667420)
13. Brockow K, Christiansen C, Kanny G, et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005;60(2):150-158. (Pubitemid 40187467)
14. Brockow K. Contrast media hypersensitivity: scope of the problem. Toxicology 2005;209(2):189-192. (Pubitemid 40568649)
15. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med 2006;354(23):2473-2483. (Pubitemid 43855050)
16. Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf 1994;10(2):93-102. (Pubitemid 24045719)
17. Meyboom RH, Hekster YA, Egberts AC, Gribnau FW, Edwards IR. Causal or casual? the role of causality assessment in pharmacovigilance. Drug Saf 1997;17(6):374-389. (Pubitemid 28017927)
18. ACR manual on contrast media, version 7, 2010. American College of Radiology. http://www.nxtbook.com/nxtbooks/arrs/contrastmediamanual2010/#/0. Published 2010. Accessed June 28, 2011.
19. Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117(2):391-397. (Pubitemid 43190153)
20. Niendorf HP, Dinger JC, Haustein J, Cornelius I, Alhassan A, Clauss W. Tolerance data of Gd-DTPA: a review. Eur J Radiol 1991;13(1):15-20.
21. Nelson KL, Gifford LM, Lauber-Huber C, Gross CA, Lasser TA. Clinical safety of gadopentetate dimeglumine. Radiology 1995;196(2):439-443.
22. Maddox TG. Adverse reactions to contrast material: recognition, prevention, and treatment. Am Fam Physician 2002;66(7):1229-1234.
23. Cohan RH, Ellis JH. Iodinated contrast material in uroradiology: choice of agent and management of complications. Urol Clin North Am 1997;24(3):471-491. (Pubitemid 27364771)
24. Hasdenteufel F, Luyasu S, Renaudin JM, et al. Anaphylactic shock after first exposure to gadoterate meglumine: two case reports documented by positive allergy assessment. J Allergy Clin Immunol 2008;121(2):527-528. (Pubitemid 351215162)
25. Galera C, Pur Ozygit L, Cavigioli S, Bousquet PJ, Demoly P. Gadoteridol-induced anaphylaxis: not a class allergy. Allergy 2010;65(1):132-134.